Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.63 |
| ▸ | THPO | P40225 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL112332 | 1.00 | SMN1; SMN2 (0.63) | SMN1; SMN2KDM4EMAPTTHRBALOX15 | |
| SCHEMBL14088106 | 1.00 | SMN1; SMN2 (0.63) | SMN1; SMN2KDM4EMAPTTHRBALOX15 | |
| SCHEMBL7999610 | 0.87 | KDM4E (0.63) | SMN1; SMN2KDM4EMAPTTHRBALOX15 | |
| SCHEMBL5599294 | 0.87 | KDM4E (0.63) | SMN1; SMN2KDM4EMAPTTHRBALOX15 | |
| SCHEMBL2298043 | 0.87 | KDM4E (0.63) | SMN1; SMN2KDM4EMAPTTHRBALOX15 | |
| SCHEMBL7999598 | 0.87 | KDM4E (0.63) | SMN1; SMN2KDM4EMAPTTHRBALOX15 | |
| SCHEMBL23870628 | 0.85 | KDM4E (0.61) | SMN1; SMN2KDM4EMAPTTHRBALOX15 | |
| SCHEMBL6815850 | 0.85 | KDM4E (0.61) | SMN1; SMN2KDM4EMAPTTHRBALOX15 | |
| SCHEMBL7758252 | 0.85 | KDM4E (0.61) | SMN1; SMN2KDM4EMAPTTHRBALOX15 | |
| SCHEMBL4984084 | 0.84 | SMN1; SMN2 (0.43) | SMN1; SMN2KDM4EMAPTTHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626414-A1 | SYNERGISTIC COMBINATIONS OF REGULATED NECROSIS INHIBITORS WITH N-ACETYLCYSTEINE | Seabelife (FR) | 2025-10-08 | — | — | EP | claimed |
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | FIRMENICH SA (CH) | 2025-10-07 | — | — | US | claimed |
| CN-118515869-A | Polysulfide polymer, preparation method and application thereof | 四川大学 | 2024-08-20 | — | — | CN | claimed |
| WO-2024115793-A1 | SYNERGISTIC COMBINATIONS OF REGULATED NECROSIS INHIBITORS WITH N-ACETYLCYSTEINE | SEABELIFE (FR) | 2024-06-06 | — | — | WO | claimed |
| US-20230210735-A1 | PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL | FIRMENICH SA (CH) | 2023-07-06 | — | — | US | claimed |
| EP-4164587-A1 | PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL | Firmenich SA (CH) | 2023-04-19 | — | — | EP | claimed |
| US-20220409526-A1 | COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERS | RETINA FOUND OF THE SOUTHWEST (US) | 2022-12-29 | — | — | US | claimed |
| US-20210395638-A1 | PREVENTION OF THE OXIDATION OF PERFUMERY RAW MATERIALS AND FOOD RAW MATERIALS | FIRMENICH SA (CH) | 2021-12-23 | — | — | US | claimed |
| WO-2021250130-A1 | PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL | FIRMENICH SA (CH) | 2021-12-16 | — | — | WO | claimed |
| EP-3856358-A2 | PREVENTION OF THE OXIDATION OF PERFUMERY RAW MATERIALS AND FOOD RAW MATERIALS | Firmenich SA (CH) | 2021-08-04 | — | — | EP | claimed |
| WO-2021127642-A1 | SELECTIVE VALORIZATION OF BIOMASS SUGARS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-06-24 | — | — | WO | claimed |
| CN-109651503-A | A kind of preparation method and application of artificial antigen | 天津国际生物医药联合研究院 | 2019-04-19 | — | — | CN | claimed |
| US-8575382-B2 | Low molecular weight pharmacological activity modulators | “Ivy Pharm” LLC (RU) | 2013-11-05 | — | — | US | claimed |
| CN-102802605-A | Stable lipid formulations of apoptosis promoters | ABBOTT LAB | 2012-11-28 | — | — | CN | claimed |
| US-20120202764-A1 | LOW MOLECULAR WEIGHT PHARMACOLOGICAL ACTIVITY MODULATORS | "IVY PHARM" JSC. (RU) | 2012-08-09 | — | — | US | claimed |
| EP-2455386-A1 | LOW MOLECULAR WEIGHT PHARMACOLOGICAL ACTIVITY MODULATORS | "Ivy Pharm" Jsc. (RU) | 2012-05-23 | — | — | EP | claimed |
| EP-2424499-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | Abbott Laboratories (US) | 2012-03-07 | — | — | EP | claimed |
| WO-2010127193-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | claimed |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBVIE INC. | 2010-11-04 | — | — | US | claimed |
| US-RE41339-E1 | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use | TRISTRATA, INC. (US) | 2010-05-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202764-A1 | LOW MOLECULAR WEIGHT PHARMACOLOGICAL ACTIVITY MODULATORS | OPRM1, SIGMAR1, TACR1 | SMN1; SMN2 3480/4885KDM4E 4082/4885MAPT 3722/4885 |
| US-20220409526-A1 | COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERS | PDE6C, STRA6, PDE6A | SMN1; SMN2 2532/4885KDM4E 3217/4885MAPT 2605/4885 |
| US-12435294-B2 | Prevention of the oxidation of perfumery raw materials and food raw materials | CUTA, MPO, GPX4 | SMN1; SMN2 2584/4885KDM4E 4695/4885MAPT 3913/4885 |
| US-20230210735-A1 | PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL | ACHE, RBP4, LPO | SMN1; SMN2 421/4885KDM4E 3481/4885MAPT 2985/4885 |
| US-20210395638-A1 | PREVENTION OF THE OXIDATION OF PERFUMERY RAW MATERIALS AND FOOD RAW MATERIALS | CUTA, MPO, GPX4 | SMN1; SMN2 2584/4885KDM4E 4695/4885MAPT 3913/4885 |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | BCL2, BAX, BCOR | SMN1; SMN2 820/4885KDM4E 3045/4885MAPT 3440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.